Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st December, 2022.17-01-2023
17-01-2023
Parmax Pharma Ltd - 540359 - Closure of Trading Window
Subject: Closure of trading window30-12-2022
Parmax Pharma Ltd - 540359 - Clarification On Price Movement.
Clarification on Price Movement.24-12-2022
Parmax Pharma Ltd - 540359 - Clarification sought from Parmax Pharma Ltd
The Exchange has sought clarification from Parmax Pharma Ltd on December 23, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.23-12-2022
Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201508-12-2022
Parmax Pharma Ltd - 540359 - Results For Quarter And Half Year Ended 30.09.2022
Results for Quarter and half year ended 30.09.202212-11-2022
Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board meeting and approval of Unaudited Financial statements for quarter and half year ended 30th September, 202212-11-2022
Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve Intimation of Board Meeting in compliance with Reg. 29 read with Reg. 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.05-11-2022
Parmax Pharma Ltd - 540359 - Clarification On Price Movement.
Clarification on Price Movement.27-10-2022
Parmax Pharma Ltd - 540359 - Clarification sought from Parmax Pharma Ltd
The Exchange has sought clarification from Parmax Pharma Ltd on October 21, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.21-10-2022